Company Overview

Update
Founders:
Robert S. Langer, Omid Farokhzad, Ulrich von Andrian
Headquarters:
Watertown, MA
Funding:
$107.60M
Categories:
Biotechnology

Selecta Biosciences, a biopharmaceutical company, develops nanoparticle immunomodulatory drugs for the treatment and prevention of diseases.

Description

Update

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Our proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.

Current Team (9)

Update

Board Members and Advisors (8)

Update

Funding Rounds (6) - $107.60M

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • Office

    480 Arsenal St

    Building One

    Watertown, MA 02472

    USA